Valuetainment “Stopping The TRT Bandwagon” - FDA Insider REVEALS Agencies SECRET War On Testosterone
Nov 30, 2025
In this discussion, Marty Makary, a physician and public health expert, dives into the evolving perception of steroids and testosterone therapy. He highlights how muscle mass influences longevity and why the FDA is addressing testosterone replacement therapy. Makary also sheds light on the unjust discrediting of hormone therapy for women, despite its significant health benefits. He emphasizes the importance of timing in hormone treatment and critiques the misinformation surrounding HRT, ultimately advocating for a better understanding of TRT and its potential advantages.
AI Snips
Chapters
Books
Transcript
Episode notes
Bodybuilding Origin Story
- Patrick Bet-David recounts wanting to be Mr. Olympia and reading 'The Steroids Bible' as a youth fascinated by bodybuilding.
- He notes cultural shift: athletes now openly discuss TRT and HRT instead of hiding steroid use.
Muscle Mass Predicts Longevity
- Marty Makary explains steroids give short-term benefits but can carry long-term harms when abused.
- He highlights that muscle mass measured by CT scan is the top predictor of longevity.
Reevaluate TRT For Eligible Men
- Marty Makary says the FDA is holding a forum on testosterone replacement to address stigma and underattention.
- He implies clinicians should consider low-dose TRT for appropriate men rather than dismissing it outright.
